Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
TD SYNNEX is an information technology services business based in the US. TD SYNNEX shares (SNX) are listed on the NYSE and all prices are listed in US Dollars. TD SYNNEX employs 8,800 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$111.42|
|52-week range||$64.14 - $130.93|
|50-day moving average||$122.41|
|200-day moving average||$119.90|
|Wall St. target price||$139.86|
|Dividend yield||$0.4 (0.36%)|
|Earnings per share (TTM)||$10.18|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-15)||N/A|
|1 month (2021-08-26)||-12.82%|
|3 months (2021-06-25)||-8.18%|
|6 months (2021-03-26)||-4.52%|
|1 year (2020-09-25)||-12.95%|
|2 years (2019-09-26)||-1.98%|
|3 years (2018-09-26)||27.34%|
|5 years (2016-09-26)||4.94%|
Valuing TD SYNNEX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TD SYNNEX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TD SYNNEX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, TD SYNNEX shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
TD SYNNEX's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1451. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into TD SYNNEX's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
TD SYNNEX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.
The EBITDA is a measure of a TD SYNNEX's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$26.9 billion|
|Operating margin TTM||4.08%|
|Gross profit TTM||$2.9 billion|
|Return on assets TTM||6.61%|
|Return on equity TTM||19.42%|
|Market capitalisation||$10.7 billion|
TTM: trailing 12 months
There are currently 859,218 TD SYNNEX shares held short by investors – that's known as TD SYNNEX's "short interest". This figure is 7.4% up from 799,850 last month.
There are a few different ways that this level of interest in shorting TD SYNNEX shares can be evaluated.
TD SYNNEX's "short interest ratio" (SIR) is the quantity of TD SYNNEX shares currently shorted divided by the average quantity of TD SYNNEX shares traded daily (recently around 137695.19230769). TD SYNNEX's SIR currently stands at 6.24. In other words for every 100,000 TD SYNNEX shares traded daily on the market, roughly 6240 shares are currently held short.
However TD SYNNEX's short interest can also be evaluated against the total number of TD SYNNEX shares, or, against the total number of tradable TD SYNNEX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TD SYNNEX's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 TD SYNNEX shares in existence, roughly 20 shares are currently held short) or 0.0378% of the tradable shares (for every 100,000 tradable TD SYNNEX shares, roughly 38 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against TD SYNNEX.
Find out more about how you can short TD SYNNEX stock.
Dividend payout ratio: 4.79% of net profits
Recently TD SYNNEX has paid out, on average, around 4.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.72% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), TD SYNNEX shareholders could enjoy a 0.72% return on their shares, in the form of dividend payments. In TD SYNNEX's case, that would currently equate to about $0.4 per share.
While TD SYNNEX's payout ratio might seem low, this can signify that TD SYNNEX is investing more in its future growth.
TD SYNNEX's most recent dividend payout was on 29 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 July 2021 (the "ex-dividend date").
TD SYNNEX's shares were split on a 2454:1000 basis on 30 November 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 2454 shares. This wouldn't directly have changed the overall worth of your TD SYNNEX shares – just the quantity. However, indirectly, the new 59.3% lower share price could have impacted the market appetite for TD SYNNEX shares which in turn could have impacted TD SYNNEX's share price.
Over the last 12 months, TD SYNNEX's shares have ranged in value from as little as $64.141 up to $130.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while TD SYNNEX's is 1.6146. This would suggest that TD SYNNEX's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TD SYNNEX provides business process services in the United States and internationally. The company distributes peripherals; and information technology systems, including system components, software, networking, communications and security equipment, consumer electronics, and complementary products, as well as designs and integrates data center equipment. It also provides systems design and integration solutions, build-to-order, and configure-to-order assembly capabilities; logistics services that comprise outsourced fulfillment, virtual distribution, and direct ship to end-users; cloud services; online services; and financing services comprising net terms, third party leasing, floor plan financing, and letters of credit backed financing and arrangements. In addition, the company offers marketing services, such as direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves resellers, system integrators, and retailers. The company was formerly known as SYNNEX Corporation and changed its name to TD SYNNEX in September 2021. TD SYNNEX was founded in 1980 and is headquartered in Fremont, California.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.